Hypoxia and TGF-β1 lead to endostatin resistance by cooperatively increasing cancer stem cells in A549 transplantation tumors

BACKGROUND: Lung cancer is the leading cause of cancer-related deaths worldwide, and treatments for lung cancer have a high failure rate. Anti-angiogenic therapy is also often ineffective because of refractory disease. Endostatin (ES) is one of the most widely-used anti-angiogenic drugs for lung can...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yuyi, Jiang, Ming, Li, Zhixi, Wang, Jiantao, Du, Chi, Yanyang, Liu, Yu, Yang, Wang, Xia, Zhang, Nan, Zhao, Maoyuan, Wang, Li, Li, Mei, Luo, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690275/
https://www.ncbi.nlm.nih.gov/pubmed/26705466
http://dx.doi.org/10.1186/s13578-015-0064-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690275/
https://www.ncbi.nlm.nih.gov/pubmed/26705466
http://dx.doi.org/10.1186/s13578-015-0064-4

Ejemplares similares